Page last updated: 2024-08-05 11:02:06
indolocarbazole
Compounds based upon an indolo[2,3-a]carbazole skeleton.
ChEBI ID: 51915
Members (10)
| Member | Definition | Role |
|---|---|---|
| 5,11-dihydroindolo[3,2-b]carbazole-12-carboxaldehyde | 5,11-dihydroindolo[3,2-b]carbazole-12-carboxaldehyde | |
| arcyriaflavin a | LSM-3627 | |
| go 6976 | Goe 6976 | |
| kt 5720 | An organic heterooctacyclic compound that is 1H,1'H-2,2'-biindole in which the nitrogens have undergone formal oxidative coupling to positions 2 and 5 of hexyl (3S)-3-hydroxy-2-methyltetrahydrofuran-3-carboxylate (the 2R,3S,5S product), and in which the 3 and 3' positions of the biindole moiety have also undergone formal oxidative coupling to positions 3 and 4 of 1,5-dihydro-2H-pyrrol-2-one. | KT 5720 |
| kt 5823 | An organic heterooctacyclic compound that is 1H,1'H-2,2'-biindole in which the nitrogens have undergone formal oxidative coupling to positions 2 and 5 of methyl (3R)-3-methoxy-2-methyltetrahydrofuran-3-carboxylate (the 2S,3R,5R product), and in which the 3 and 3' positions of the biindole moiety have also undergone formal oxidative coupling to positions 3 and 4 of 1-methyl-1,5-dihydro-2H-pyrrol-2-one. | KT 5823 |
| kt 5926 | An organic heterooctacyclic compound that is 5-propoxy-1H,1'H-2,2'-biindole in which the nitrogens have undergone formal oxidative coupling to positions 2 and 5 of methyl (3R)-3-hydroxy-2-methyltetrahydrofuran-3-carboxylate (the 2S,3R,5R product), and in which the 3 and 3' positions of the biindole moiety have also undergone formal oxidative coupling to positions 3 and 4 of 1,5-dihydro-2H-pyrrol-2-one. | KT 5926 |
| lestaurtinib | LSM-1231 | |
| midostaurin | An organic heterooctacyclic compound that is the N-benzoyl derivative of staurosporine. | midostaurin |
| rebeccamycin | An N-glycosyl compound consisting of a heteropolycyclic ring system with a glucosyl group attached to one of the indolic nitrogens. | rebeccamycin |
| sb 218078 | LSM-1274 |
Research
Studies (1,871)
| Timeframe | Studies, Drugs in This Class (%) | All Drugs % |
|---|---|---|
| pre-1990 | 3 (0.16) | 18.7374 |
| 1990's | 345 (18.44) | 18.2507 |
| 2000's | 848 (45.32) | 29.6817 |
| 2010's | 541 (28.92) | 24.3611 |
| 2020's | 134 (7.16) | 2.80 |
Study Types
| Publication Type | Studies, Drugs in This Class (%) | All Drugs (%) |
|---|---|---|
| Trials | 55 (2.73%) | 5.53% |
| Reviews | 118 (5.86%) | 6.00% |
| Case Studies | 32 (1.59%) | 4.05% |
| Observational | 2 (0.10%) | 0.25% |
| Other | 1,806 (89.72%) | 84.16% |